Canada Post Corp Registered Pension Plan purchased a new position in Agilent Technologies, Inc. (NYSE:A - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 37,906 shares of the medical research company's stock, valued at approximately $5,092,000.
Several other institutional investors and hedge funds have also bought and sold shares of the stock. Wellington Management Group LLP increased its stake in shares of Agilent Technologies by 0.6% during the fourth quarter. Wellington Management Group LLP now owns 9,306,805 shares of the medical research company's stock valued at $1,250,276,000 after purchasing an additional 59,781 shares in the last quarter. Geode Capital Management LLC raised its stake in Agilent Technologies by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 7,002,671 shares of the medical research company's stock valued at $938,291,000 after buying an additional 53,992 shares during the last quarter. Pictet Asset Management Holding SA boosted its holdings in Agilent Technologies by 0.9% in the fourth quarter. Pictet Asset Management Holding SA now owns 5,213,739 shares of the medical research company's stock worth $700,414,000 after acquiring an additional 47,495 shares in the last quarter. Norges Bank purchased a new stake in shares of Agilent Technologies in the fourth quarter worth $456,963,000. Finally, Cantillon Capital Management LLC raised its position in shares of Agilent Technologies by 0.5% in the 4th quarter. Cantillon Capital Management LLC now owns 3,316,557 shares of the medical research company's stock worth $445,546,000 after purchasing an additional 17,627 shares during the last quarter. 87.42% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on A. TD Cowen upped their target price on shares of Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research note on Thursday, April 10th. Barclays decreased their price target on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. StockNews.com raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a report on Tuesday, December 24th. Robert W. Baird dropped their price target on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating on the stock in a research note on Thursday, February 27th. Finally, Wells Fargo & Company reduced their price target on shares of Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating for the company in a research report on Thursday. Seven equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat.com, Agilent Technologies has a consensus rating of "Moderate Buy" and a consensus target price of $144.58.
View Our Latest Report on A
Agilent Technologies Price Performance
Shares of Agilent Technologies stock traded down $0.32 on Friday, hitting $102.38. 1,769,911 shares of the company traded hands, compared to its average volume of 1,856,940. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $155.35. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. The business has a 50-day simple moving average of $119.55 and a 200 day simple moving average of $132.49. The stock has a market capitalization of $29.19 billion, a P/E ratio of 23.54, a price-to-earnings-growth ratio of 2.89 and a beta of 1.19.
Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The company had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. Research analysts expect that Agilent Technologies, Inc. will post 5.54 earnings per share for the current fiscal year.
Agilent Technologies Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be given a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies's dividend payout ratio (DPR) is currently 22.76%.
Insider Buying and Selling at Agilent Technologies
In related news, CEO Padraig Mcdonnell sold 1,911 shares of the business's stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the sale, the chief executive officer now owns 39,652 shares in the company, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Daniel K. Podolsky sold 1,819 shares of the firm's stock in a transaction on Monday, March 31st. The stock was sold at an average price of $116.46, for a total value of $211,840.74. Following the transaction, the director now owns 35,737 shares in the company, valued at $4,161,931.02. The trade was a 4.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 5,638 shares of company stock worth $731,229 over the last 90 days. Company insiders own 0.26% of the company's stock.
About Agilent Technologies
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Stories
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
